|Articles|January 11, 2022

Pharmaceutical Executive

  • Pharmaceutical Executive-01-01-2022
  • Volume 42
  • Issue 1

Our View on 2022: Pharm Exec’s Annual Industry Outlook

Supply chain issues, psychedelic medicines, immunotherapies, social engagement, telemedicine, access barriers, corporate branding, and the rise of Chinese biotech are industry topics that deserve a closer look as we head into the future.

Follow the links below to read about each trend:

Logistics - Julian Upton

Psychedelics - Elaine Quilici

Immunotherapies - Elaine Quilici

Social Influence - Fran Pollaro

Patient Engagement - Andy Studna

Health Plan Burdens - Lisa Henderson

Corporate Branding - Fran Pollaro

Chinese Biotech - Julian Upton

Articles in this issue

over 4 years ago

Keeping Tabs on Quality: The Rise of Digital

over 4 years ago

China Invests in Building Biotech

over 4 years ago

Branding Takes on a New Look

over 4 years ago

Addressing Access Burdens

over 4 years ago

Meeting the Patient—Virtually

over 4 years ago

The Age of Influence

over 4 years ago

Boosting Immunotherapies

over 4 years ago

Pharma’s Psychedelic Experience

over 4 years ago

Supply Chain Procurement

over 4 years ago

Breaking New Ground in Biopharma

Newsletter

Lead with insight with the Pharmaceutical Executive newsletter, featuring strategic analysis, leadership trends, and market intelligence for biopharma decision-makers.

Subscribe Now!

Related Content